Elon Musk costs Eli Lilly millions of dollars because of Twitter's fake ...

MARCA.com - 12 Nov 2022
He hasn't been in charge for long, but Elon Musk has already encountered several problems within Twitter, the platform he recently acquired.

Yahoo Finance - 08 Nov 2024
...

Eli Lilly Posts a Huge Earnings Miss. Should Investors Be Worried?

The Motley Fool - 06 Nov 2024
Eli Lilly Posts a Huge Earnings Miss. Should Investors Be Worried? ...

Eli Lilly Has a Major Problem With Its Weight Loss Drugs Zepbound and Mounjaro

Futurism - 02 Nov 2024
Eli Lilly Has a Major Problem With Its Weight Loss Drugs Zepbound and Mounjaro ...

Eli Lilly's rare sales miss for weight-loss drug sends shares tumbling

Reuters - 30 Oct 2024
Eli Lilly's rare sales miss for weight-loss drug sends shares tumbling ...

Eli Lilly sues over knockoffs of signature weight loss drug, Zepbound

USA TODAY - 21 Oct 2024
Eli Lilly sues over knockoffs of signature weight loss drug, Zepbound ...

As Eli Lilly, compounders battle over weight loss drugs, patients are caught in the middle

STAT - 11 Oct 2024
As Eli Lilly, compounders battle over weight loss drugs, patients are caught in the middle ...

Eli Lilly's tirzepatide is off the FDA's shortage list: What it means for patients

Fox Business - 16 Oct 2024
Eli Lilly's tirzepatide is off the FDA's shortage list: What it means for patients ...

The Crackdown on Compounded GLP-1 Meds Has Begun

WIRED - 10 Oct 2024
The Crackdown on Compounded GLP-1 Meds Has Begun ...

Britain to study use of Lilly's weight loss drug to get people back to work

Reuters UK - 15 Oct 2024
Britain to study use of Lilly's weight loss drug to get people back to work ...

Compounding group sues FDA for removing Lilly’s obesity drug from its shortages list

STAT - 08 Oct 2024
Compounding group sues FDA for removing Lilly’s obesity drug from its shortages list ...

Eli Lilly Just Hit a Milestone That Disappointed. Here's Why You Should Still Buy the Stock.

The Motley Fool - 08 Nov 2024
Eli Lilly Just Hit a Milestone That Disappointed. Here's Why You Should Still Buy the Stock. ...

Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly

BioWorld Online - 07 Nov 2024
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly ...

How Eli Lilly Outpaces Nvidia—Here Is One Chart

Forbes - 15 Oct 2024
How Eli Lilly Outpaces Nvidia—Here Is One Chart ...

Shares in weight-loss drugmaker Eli Lilly fall on disappointing sales

Financial Times - 30 Oct 2024
Shares in weight-loss drugmaker Eli Lilly fall on disappointing sales ...

Lilly reports Q3 2024 financial results highlighted by strong volume-driven revenue growth from New Products

Investors | Eli Lilly and Company - 30 Oct 2024
Lilly reports Q3 2024 financial results highlighted by strong volume-driven revenue growth from New Products ...

While Novo and Lilly's market value declined in Q3, BMS, Gilead and Sanofi surged: GlobalData

FiercePharma - 08 Nov 2024
While Novo and Lilly's market value declined in Q3, BMS, Gilead and Sanofi surged: GlobalData ...

StockWatch: Investors Hammer Lilly as GLP-1 Sales Miss Forecasts

Genetic Engineering & Biotechnology News - 01 Nov 2024
StockWatch: Investors Hammer Lilly as GLP-1 Sales Miss Forecasts ...

Eli Lilly stock sinks after Q3 earnings miss Wall Street expectations

Yahoo Finance - 30 Oct 2024
Eli Lilly stock sinks after Q3 earnings miss Wall Street expectations ...

Eli Lilly stock tumbles after drug giant misses estimates and slashes profit guidance

CNBC - 30 Oct 2024
Eli Lilly stock tumbles after drug giant misses estimates and slashes profit guidance ...

Eli Lilly